30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mike Sherman

Track

Insider profile

Currently holds a position at Endocyte Inc

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
17 82% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -2%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
President, Chief Executive Officer Endocyte Inc Dec. 21, 2018 -
President, Chief Executive Officer, Chief Financial Officer, Director Endocyte Inc June 16, 2016 - Feb. 20, 2017
Chief Financial Officer, Chief Operating Officer Endocyte Inc June 16, 2014 - June 16, 2016
Mike Sherman's trades of Premier Miton Group PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-10 2024-04-10
B Purchase
16,580
472.16
£1,419,205 		16,580 472.16 £1,419,205
2024-04-09 2024-04-09
B Purchase
44,812
165.62
£3,884,130 		44,812 165.62 £3,884,130
2023-06-01 2023-06-01
S Sale
82,617
494.65
£4,880,608 		82,617 494.65 £4,880,608
2023-06-01 2023-06-01
B Purchase
27,500
0.82
£22,613 		27,500 0.82 £22,613
2023-05-16 2023-05-12
US Chimerix Inc (CMRX)
B Purchase
75,015 +625.9%
1.12
US$84,122 		75,015 +625.9% 1.12 US$84,122
2023-05-16 2023-05-12
US Chimerix Inc (CMRX)
B Purchase
11,985 +inf%
1.13
US$13,530 		11,985 +inf% 1.13 US$13,530
2023-03-28 2023-03-28
S Sale
19,926
1.01
£20,124 		19,926 1.01 £20,124
2023-03-20 2023-03-17
B Purchase
3,000
6.65
£19,950 		3,000 6.65 £19,950
2022-10-28 2022-10-28
B Purchase
50,000
0.87
£43,500 		50,000 0.87 £43,500
2022-09-08 2022-09-08
B Purchase
937
1.02
£951 		937 1.02 £951
2022-08-18 2022-08-18
B Purchase
8,963
1.15
£10,343 		8,963 1.15 £10,343
2022-08-18 2022-08-18
S Sale
9,000
1.15
£10,350 		9,000 1.15 £10,350
2022-08-05 2022-08-05
B Purchase
14,700
0.01
£171 		14,700 0.01 £171
2022-08-05 2022-08-05
B Purchase
14,700
1.17
£17,136 		14,700 1.17 £17,136
2020-10-19 2020-10-19
B Purchase
6,527
4.75
£31,003 		6,527 4.75 £31,003
2020-03-16 2020-03-12
US Chimerix Inc (CMRX)
B Purchase
72,995 +243.3%
1.45
US$105,653 		72,995 +243.3% 1.45 US$105,653
2019-09-27 2019-09-27
B Purchase
20,000
5.70
£114,000 		20,000 5.70 £114,000
2019-05-20 2019-05-20
US Chimerix Inc (CMRX)
B Purchase
30,000 +inf%
3.48
US$104,316 		30,000 +inf% 3.48 US$104,316
2018-12-28 2018-12-24
GB BT Group PLC (BT.A)
B Purchase
6,493
15.46
US$100,382 		6,493 15.46 US$100,382